Deficiencia de lipasa ácida lisosomal, una patología infrecuente.

Catalina Gómez-Duarte, Víctor García, Verónica Botero, Ana Aristizabal, Gabriel Echeverri, Harry Pachajoa

Journal: Gaceta medica de Mexico 2020;155(3):291-297

PMID: 31219466

Abstract

Lysosomal acid lipase deficiency is a genetic disease with a low prevalence and high morbidity and mortality in children and adults. It is characterized by an alteration of lipid metabolism, which generates cholesterol and triglyceride esters deposits in the body. Its clinical presentation depends on enzymatic activity. This condition should be suspected in patients with lipid or liver alterations after ruling out other diagnoses. Currently, there is the option of using a recombinant enzyme, which can improve lipid and liver parameters, as well as disease progression. Establishing a timely diagnosis in order to initiate specific treatment early is imperative for the prevention of morbidity and mortality. The purpose of this work is to perform a review of the literature about lysosomal acid lipase deficiency and to guide about its pathophysiology, clinical manifestations, diagnosis and treatment.

Copyright: © 2019 SecretarÍa de Salud.

Address: Fundación Valle del Lili, Cali, Colombia.; Clínica de la Costa, Universidad de la Sabana, Chía; Colombia.; Universidad Icesi, Cali. Colombia.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.